Benitec Biopharma Inc.: Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...
manilatimes20h
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
The fourth Subject was safely treated with the low-dose of BB-301 in December 2024, and the fifth Subject was safely treated with the low-dose of BB-301 in early February 2025. The sixth Subject is ...
Chronic heartburn? You might be at risk for a rare but deadly cancer! Here are signs to watch out for during acid reflux
Think acid reflux is harmless? Your heartburn could be hiding a deadly cancer secret. Here are the symptoms you should never ...
Daily3d
Severe Dysphagia Linked to Shorter Survival and Higher Mortality After Percutaneous Endoscopic Gastrostomy: Study
Japan: A recent study found that severe dysphagia in patients undergoing percutaneous endoscopic gastrostomy (PEG) was linked ...